Document Detail


Effect of histamine H2-receptor antagonists on vitamin B12 absorption.
MedLine Citation:
PMID:  1358279     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To discuss the potential of histamine H2-receptor antagonists (H2RAs) to cause malabsorption of vitamin B12 (cyanocobalamin). DATA SOURCES: Pertinent literature was identified via a MEDLINE search. Journals and references cited in published articles also were used as data sources. STUDY SELECTION: Studies evaluating the effect of H2RAs on vitamin B12 absorption were reviewed. DATA SYNTHESIS: H2RAs decrease acid secretion by the gastric parietal cells. Gastric acid and pepsin produced by these cells are required for the cleavage of vitamin B12 from dietary sources. Intrinsic factor (IF), also produced by gastric parietal cells, is required for vitamin B12 absorption from the gastrointestinal tract. Although H2RAs have not conclusively been shown to decrease IF secretion, studies have demonstrated a significant reduction in food-bound vitamin B12 absorption secondary to decreased acid secretion in patients taking these drugs. CONCLUSIONS: H2RAs have the potential to cause vitamin B12 deficiency. This may be important in patients with inadequate stores of vitamin B12 (e.g., poor diet), particularly those receiving H2RA therapy continuously for more than two years. Healthcare providers should be aware of this potential adverse effect.
Authors:
R W Force; M C Nahata
Related Documents :
1731249 - Limbs generated at site of tail amputation in marbled balloon frog after vitamin a trea...
8361989 - Interaction between vitamin b6 deficiency and low efa dietary intake on kidney phosphol...
6138349 - Vitamin k-dependent carboxylase. demonstration of a vitamin k- and o2-dependent exchang...
16715619 - Hypertension as a low-grade systemic inflammatory condition that has its origins in the...
3920049 - Is coenzyme m bound to factor f430 in methanogenic bacteria? experiments with methanobr...
15364709 - Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiv...
2789979 - Effects of some poorly digestible carbohydrates on bile acid bacterial transformations ...
8111249 - Incorporation of radioactive phosphate from adenosine triphosphate into phosphatidylino...
21910059 - Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway a...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  26     ISSN:  1060-0280     ISO Abbreviation:  Ann Pharmacother     Publication Date:  1992 Oct 
Date Detail:
Created Date:  1992-12-16     Completed Date:  1992-12-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1283-6     Citation Subset:  IM    
Affiliation:
College of Pharmacy, Ohio State University, Columbus 43210.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cimetidine / therapeutic use
Clinical Trials as Topic
Histamine H2 Antagonists / pharmacology*,  therapeutic use
Humans
Intestinal Absorption / drug effects*
Peptic Ulcer / physiopathology,  therapy
Ranitidine / therapeutic use
Vitamin B 12 / metabolism*
Chemical
Reg. No./Substance:
0/Histamine H2 Antagonists; 51481-61-9/Cimetidine; 66357-35-5/Ranitidine; 68-19-9/Vitamin B 12

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recent developments in the pathophysiology and treatment of hepatic encephalopathy.
Next Document:  Remarkable increase in CD26-positive T cells in patients with human T lymphotropic virus type I (HTL...